Company Filing History:
1 out of 27 
1 out of 1 
1 out of 31 
Years Active: 2020
Title: Ondrej Stepanek: Innovator in Estrogen-Dependent Disease Research
Introduction
Ondrej Stepanek is a notable inventor based in Liberec, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of selective inhibitors for 17β-hydroxysteroid-dehydrogenases. His work focuses on compounds that may aid in the diagnosis and treatment of estrogen-dependent diseases.
Latest Patents
Ondrej Stepanek holds a patent for "15β-substituted estrone derivatives as selective inhibitors of 17β-hydroxysteroid-dehydrogenases, method of preparation and use thereof." This patent describes 15β-substituted derivatives of estrone, which are characterized by a general formula where various substituents can be selected from a specific group. The compounds developed under this patent have potential applications in medical diagnostics and treatment.
Career Highlights
Throughout his career, Ondrej Stepanek has worked at esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Institute of Molecular Genetics of the Czech Academy of Sciences. His research has contributed to advancements in understanding hormone-related diseases.
Collaborations
Ondrej has collaborated with notable colleagues, including Martin Kotora and Eva Prchalova. Their joint efforts have furthered research in the field of biochemistry and have led to innovative solutions in medical science.
Conclusion
Ondrej Stepanek's work exemplifies the intersection of innovation and medical research. His contributions to the development of selective inhibitors for estrogen-dependent diseases highlight the importance of scientific inquiry in improving health outcomes.